# Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

> **NCT06904482** · PHASE2 · RECRUITING · sponsor: **Case Comprehensive Cancer Center** · enrollment: 36 (estimated)

## Conditions studied

- aGVHD
- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** Haplo-Identical / Cord Blood Transplant

## Key facts

- **NCT ID:** NCT06904482
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-13
- **Primary completion:** 2027-02-24
- **Final completion:** 2030-02-25
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06904482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06904482, "Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06904482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*